National Institute for Health and Clinical Excellence (NICE)
Critical Illness
As providers increasingly look to partial payments on critical illness policies, Phil Jeynes warns advisers to be careful in their comparisons.
23 May 2012
•
6 min read
Critical Illness
In the first in a series of articles exploring the finer points of critical illness protection, CIExpert's Alan Lakey discusses value judgements.
17 May 2012
•
3 min read
PMI
Care provided to patients with diabetes is in a ‘state of crisis' a specialist health lawyer has warned.
16 May 2012
•
PMI
The National Institute for Health and Clinical Excellence, (NICE), has opened a consultation on draft guidance which does not recommend bevacizumab (Avastin, Roche), for metastatic breast cancer, when used in combination with the chemotherapy drug, capecitabine....
18 April 2012
•
PMI
Two more cancer drugs have been provisionally banned for NHS after it was decided they were too expensive for the potential results.
14 February 2012
•
2 min read
Critical Illness
Britain will be facing a bill of more than £15bn a year to diagnose and treat cancer in ten years time, new research has suggested.
12 December 2011
•
3 min read
PMI
The National Institute for Health and Clinical Excellence (NICE) has finalised new quality standards for end of life care for patients and their families and carers.
30 November 2011
•
2 min read
PMI
The National Institute for Health and Clinical Excellence (Nice) has banned another breast cancer drug from routine NHS use.
10 November 2011
•
2 min read
uncategorised
Axa PPP's Fergus Craig has a keen eye on PMI. Paul Robertson asks him how the market is improving.
17 October 2011
•
8 min read
PMI
The ongoing dispute between Bupa and surgeons' representative bodies is now on the verge of entering its fourth month and has earned the title "saga" at COVER.
02 August 2011
•
2 min read
